Effectiveness of anti-IL-5/5Rα biologics in severe asthma in real-world studies: a systematic review and meta-analysis
Background Three biologics targeting interleukin 5 (anti-IL-5) or its receptor-α (anti-IL-5Rα) are approved for patients with severe asthma. Methods We systematically searched the literature published in Medline and Embase up to 1 May 2023 to identify observational studies and nonrandomised trials t...
Saved in:
| Main Authors: | Christos Kyriakopoulos, Efthymia Papadopoulou, Dimitrios Potonos, Konstantinos Exarchos, Evangelos Beris, Christina Aggelopoulou, Stavros Tryfon, Athena Gogali, Konstantinos Kostikas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2025-03-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/11/2/00625-2024.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the Impact of Triple Therapy on Mortality in Copd: The End is the Beginning?
by: Konstantinos Kostikas, et al.
Published: (2022-12-01) -
Oscillometry Assesses Small Airway Disease and Reveals Peripheral Lung Pathology in Early Pulmonary Fibrosis: A Cross-Sectional Study
by: Athena Gogali, et al.
Published: (2024-12-01) -
Biologics in COPD: The Road is Still Long and Winding
by: Konstantinos Kostikas, et al.
Published: (2025-05-01) -
2025 GOLD Report: What is New and What is Noteworthy for the Practicing Clinician
by: Konstantinos Kostikas, et al.
Published: (2025-01-01) -
Proposal for a 4-Level Classification System of Severe COPD Exacerbation According to Healthcare Resource Utilization
by: Georgios Hillas, et al.
Published: (2024-12-01)